Raymond James Financial Services Advisors, Inc. Galmed Pharmaceuticals Ltd. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $69.1 Billion
  • Q2 2024

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.29 - $84.61 $8,818 - $2.57 Million
-30,410 Reduced 52.15%
27,900 $13,000
Q3 2022

Oct 25, 2022
SELL
$0.35 - $59.37 $2,100 - $356,220
-6,000 Reduced 9.33%
58,310 $18,000
Q2 2022

Aug 12, 2022
BUY
$0.44 - $1.77 $440 - $1,770
1,000 Added 1.58%
64,310 $42,000
Q1 2022

May 11, 2022
BUY
$1.23 - $2.07 $47,792 - $80,431
38,856 Added 158.89%
63,310 $101,000
Q4 2021

Feb 08, 2022
BUY
$1.75 - $3.03 $5,512 - $9,544
3,150 Added 14.79%
24,454 $45,000
Q3 2021

Nov 02, 2021
BUY
$2.41 - $3.33 $10,977 - $15,168
4,555 Added 27.2%
21,304 $59,000
Q2 2021

Aug 11, 2021
SELL
$2.24 - $3.9 $757 - $1,318
-338 Reduced 1.98%
16,749 $51,000
Q1 2021

May 14, 2021
BUY
$3.19 - $5.4 $54,507 - $92,269
17,087 New
17,087 $59,000

About Galmed Pharmaceuticals Ltd.

GLMD Quotes by TradingView
  • Ticker GLMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,088,400
  • Market Cap $153M
  • Description
  • Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...
More about GLMD
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email